These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25265261)

  • 21. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis: state of the art 2013.
    de la Brassinne M; Nikkels A
    Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
    Shi HJ; Zhou H; Ma AL; Wang L; Gao Q; Zhang N; Song HB; Bo KP; Ma W
    Br J Dermatol; 2019 Nov; 181(5):1028-1037. PubMed ID: 30822359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis.
    Al-Hamamy HR; Al-Mashhadani SA; Mustafa IN
    Int J Dermatol; 2014 Dec; 53(12):1531-5. PubMed ID: 24738793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S; Rozenblit M; Lebwohl M
    J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing acitretin use in patients with plaque psoriasis.
    Chiricozzi A; Panduri S; Dini V; Tonini A; Gualtieri B; Romanelli M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
    Lee E; Koo J
    J Dermatolog Treat; 2005 Apr; 16(2):102-7. PubMed ID: 16019624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of various methods of psoriasis treatment on somatotrophin axis hormones in serum.
    Damasiewicz-Bodzek A; Kos-Kudła B; Suwała-Jurczyk B
    J Clin Pharm Ther; 2006 Aug; 31(4):343-9. PubMed ID: 16882103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 31. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
    Carlin CS; Callis KP; Krueger GG
    Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type.
    Kopp T; Karlhofer F; Szépfalusi Z; Schneeberger A; Stingl G; Tanew A
    Br J Dermatol; 2004 Oct; 151(4):912-6. PubMed ID: 15491438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy.
    Strober BE; Poulin Y; Teller C; Wang Y; Williams DA; Goldblum OM
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1701-6. PubMed ID: 24422992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of pediatric psoriasis with acitretin: A review.
    Subedi S; Yu Q; Chen Z; Shi Y
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29094450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study.
    Kampitak T; Asawanonda P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S20-4. PubMed ID: 17718265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.